Walvax Biotechnology: RQ3013

Vaccine Type: RNA

This vaccine may also be referred to as SARS-CoV-2 mRNA Chimera Vaccine

Vaccine Trial & Approval Tracker

This vaccine has reached Phase 1 trials.

About Trial Phases

Phase 1: 2 Trials

Phase 2: 0 Trials

There are no trials for this phase.

Phase 3: 0 Trials

There are no trials for this phase.

Approvals

This vaccine is not yet approved.

Registered Trials